Fintel reports that on October 10, 2024, Barclays upgraded their outlook for CVS Health (NYSE:CVS) from Equal-Weight to ...

On Oct. 8, Keybanc analyst John Vinh maintained Micron Technology with an Overweight and lowered the price target from $145 ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on ... Mok CFA covers the Healthcare sector, focusing on stocks such as Centene, CVS Health, and Humana. The word on The Street in general, ...

Sixty-two percent of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans ...

CVS Health Corp (CVS) closed up more than +1% after Barclays upgraded the stock to overweight from equal weight with a price target of $82. Bank of New York Mellon Corp/The (BK), Blackrock Inc (BLK), ...

CVS Health Corp (CVS) is up more than +1% after Barclays upgraded the stock to overweight from equal weight with a price target of $82.

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

Shares rose 0.4%. Market Insight Emerging market funds saw record inflows recently, although near-term risks persist, Barclays said. Equity funds focusing on emerging market saw the largest inflows on ...

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...

This is one of them: Drinking several cups of caffeinated coffee or tea a day may protect against Type 2 diabetes, coronary heart disease and stroke. The findings, published Tuesday in the Journal ...

A Woman Won South Korea’s First Literature Nobel. That Says a Lot. While Han Kang’s victory was celebrated as a crowning cultural achievement for her country, her work also represents a form ...

Hurricane Milton Is Linked to 11 Deaths, Many Far From Landfall Rescuers pulled scores of people from flooded or damaged buildings and vehicles on Thursday after Hurricane Milton tore across ...